U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Clinical Search and Evaluation Lead - Neurology

Biology & BiotechUpdated on Nov 14
Full-timeNo salary listed

About the Job

Requirements

  • An advanced degree in medicine, clinical science, neuroscience, or a related scientific discipline is required; a medical degree is advantageous but not essential.
  • Several years of relevant experience in clinical development, translational medicine, medical affairs, clinical research, or a closely related scientific role within the biopharmaceutical industry.
  • Deep knowledge of neurology or neuroscience, including patient populations, standards of care, disease biology, and clinical development pathways.
  • Demonstrated expertise in clinical trial design and the ability to critically interpret clinical data, endpoints, development plans, and benefit-risk considerations.
  • A science-driven mindset and judgment to distinguish promising innovation from ideas that are not sufficiently differentiated, feasible, or evidence-based.
  • Ability to balance scientific ambition with practical considerations, including development risk, timelines, resources, and cost.
  • Strong external orientation and curiosity, with confidence scouting the market and engaging credibly with clinicians, scientists, specialists, and innovators.
  • Clear, credible, and influential communication skills, including the ability to translate complex science and clinical evidence for cross-functional teams and senior leaders.
  • A collaborative, ambitious, and pragmatic approach, with interest in developing toward broader strategic responsibilities over time.
  • Fluent written and spoken English.
  • Confidence using digital and artificial intelligence-enabled tools.
  • Willingness to travel up to 15% to 20%.

Responsibilities

  • Monitor the external neuroscience landscape to identify clinical-stage opportunities with potential patient impact.
  • Scout the landscape, engage with specialists and innovators, and translate scientific and clinical evidence into clear, informed recommendations.
  • Build and maintain a forward-looking neurology Business Development and Mergers & Acquisitions roadmap informed by clinical, scientific, treatment, and competitive trends.
  • Scout, map, and monitor clinical-stage assets and emerging approaches across priority neurological diseases, patient populations, and treatment modalities.
  • Engage with external clinicians, scientists, specialists, and innovators to understand new ideas, emerging evidence, and areas of unmet need.
  • Critically evaluate clinical trial design, clinical data, development plans, endpoints, patient populations, standards of care, risks, and potential benefits.
  • Interpret complex scientific and clinical evidence and translate it into clear, balanced, practical recommendations for cross-functional and senior stakeholders.
  • Prioritize opportunities based on scientific quality, clinical differentiation, patient relevance, development feasibility, risk, resource requirements, and cost.
  • Support rigorous cross-functional evaluation by challenging assumptions, identifying evidence gaps and risks, and shaping practical mitigation plans.
  • Build external networks, represent the company professionally at scientific and industry events, and track emerging areas of strategic interest in neuroscience.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs